Deni Avdija, the Back Injury, and the World Cup Ticket Portland Held Back: Who Really Holds the Power in World Basketball?

In mid-February, Deni Avdija received an unwanted call from the Portland Trail Blazers. The message was brief: he would not be cleared to join the Israeli national team for the 2026 FIBA World Cup qualifiers. The stated reason was a back injury — a phrase Avdija had heard far too often this season. In January, he felt tightness in his back and sat out games. In February, the pain returned. He ended up missing 16 of 24 games for Portland, a stretch long enough that the coaching staff had to rework their entire rotation plan. On his personal social media, the 23-year-old broke his usual silence with a long explanation: "I usually don't feel the need to explain myself to anyone. But this time, it matters." Israeli fans didn't need to read further to grasp the severity. Their national team is 2-6 after eight World Cup qualifying games. Europe is one of the most brutal qualifying zones on the planet, where Nikola Jokic of Serbia, Victor Wembanyama and Rudy Gobert of France, Lauri Markkanen of Finland, and Dennis Schroder of Germany treat national team duty as sacred. More than 30 NBA players have participated in this qualifying window. Losing their best player — in such a competitive environment — is a crushing blow to an already fragile campaign. I have spent years covering international qualifying windows, and when I look at Israel's run, I keep finding a pattern that no single stat sheet highlights: every time the team needs a playmaker to stretch the defense with ball-handling and wing penetration, no one steps up to fill that void. Avdija is not just a scorer. He is the center of Israel's entire offensive system. He operates as a point-forward — receiving the ball in the backcourt, initiating the offense, reading situations, and creating opportunities for himself and his teammates. Without him, Israel is forced into a more conventional but far more predictable attack: traditional pick-and-roll, more isolation, fewer transition opportunities. The result is a team that is easier to scout and easier to defend. A 2-6 record reflects exactly that dependence. But this story is not just about Avdija or Israel. It exposes a silent fault line between the NBA and FIBA. Every contract has two pages: one public, one real. The public page of this case is a serious medical diagnosis — a "complex back injury" — clearly documented in Portland's records. The real page is a power structure in which NBA teams hold absolute authority over whether their players suit up for national teams. The NBA has no obligation to release players for FIBA windows. Teams can cite medical reasons to hold players back, and there is no independent verification mechanism to challenge their assessments. Giannis Antetokounmpo has been in nearly identical situations. This has happened before, and it will happen again. From Portland's perspective, the decision makes perfect sense. Avdija was born in January 2026 — he is at the most critical growth stage of his career. His rookie-scale contract, signed in 2026, is approaching extension eligibility, a financially sensitive moment. He is a central piece of the franchise's rebuilding plan alongside Scoot Henderson and Shaedon Sharpe. Portland holds a treasure trove of future first-round picks from the Damian Lillard trade. Avdija's health is a strategic asset. A recurring back injury would not only derail his development — it would significantly diminish his trade value. Scandals don't fall from the sky. They are initialed, scheduled, and staged step by step. In this case, no one initialed anything, no one scheduled anything. But Avdija's absence from Israel's roster is a reminder that the corridors of power in world basketball are being decided not on FIBA courts, but in the medical rooms of NBA teams. The dip in Avdija's performance after returning for the final 18 games of the season validates Portland's concern. Minutes dropped. Scoring dropped. Efficiency dropped. People look at the scoreboard. I look at who gets what after the scoreboard. The plain truth is that Avdija was not ready for the intensity of World Cup qualifying — with its packed schedule, constant travel, and limited recovery time. A summer of FIBA play could have pushed his body beyond its limits. When a 23-year-old player has to compete with a body that hasn't fully healed, the consequences go far beyond statistics — they can reshape an entire career. Avdija is not the kind of player who avoids national duty. His history says the opposite. He has shown up for his national team while in pain, at less than 100 percent, even during a contract year — a time when other players typically prioritize career security. "My commitment to the national team will never be questioned," he emphasized in his post. Most Israeli fans understand that the decision wasn't his. But understanding is not the same as acceptance. Their frustration is legitimate, and the backlash on Israeli social media reflects a deeper pain: for the first time in years, they watch their team drift without a lifeguard on duty. Israel, at 2-6 through eight games, has almost certainly lost its chance to reach the World Cup. Even with Avdija in the lineup, the road ahead would have been brutally difficult because Europe's qualifying zone does not forgive mistakes. But there is a harsher reality: without a fundamental change in how the NBA and FIBA collaborate, situations like this will keep repeating. Each time, a national team from a smaller market pays the price. Big teams have depth and multiple star replacements. Small teams have one. I don't trust testimony. I trust fingerprints on contracts and footprints in corridors. In this case, no contract was forged and no corridor was watched. But there is a medical diagnosis that no one outside Portland's staff can verify, and a power structure in which the voice of the Israeli Basketball Federation carries almost no weight. The fan backlash may fade once the qualifying window closes. But the question of fairness in international basketball will not disappear. At 23, with a whole future ahead, sometimes the right decision isn't made on the court — it's made in the medical room. And sometimes, the biggest loser isn't the player who sits out, but the national team that must step onto the floor without its only star.